Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle

Press Release – September 15, 2021

Illumina, Inc. has selected NewStem as one of seven new genomics companies to join the third global funding cycle of Illumina Accelerator. The global company creation engine, focused on partnering with entrepreneurs to build breakthrough genomics startups, invested in four companies for the third funding cycle of Illumina Accelerator Cambridge, UK, and three companies for the 13th funding cycle of Illumina Accelerator San Francisco Bay Area.